A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery

BACKGROUND AND AIMS: Tranexamic acid (TA) is used for prophylactic antifibrinolysis in coronary artery bypass surgeries to reduce bleeding. We evaluated the efficacy of two different doses of TA for prophylactic antifibrinolysis in patients undergoing primary coronary artery bypass grafting (CABG) s...

Descripción completa

Detalles Bibliográficos
Autores principales: McHugh, Stephen M, Kolarczyk, Lavinia, Lang, Robert S, Wei, Lawrence M, Jose, Marquez, Subramaniam, Kathirvel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787140/
https://www.ncbi.nlm.nih.gov/pubmed/27013747
http://dx.doi.org/10.4103/0019-5049.176279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787140/
https://www.ncbi.nlm.nih.gov/pubmed/27013747
http://dx.doi.org/10.4103/0019-5049.176279

Ejemplares similares